We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diabetes Prevalence Increased in Hospitalized Patients

By LabMedica International staff writers
Posted on 08 Sep 2017
Print article
The prevalence of diabetes is increasing in Germany and at present, the metabolic disease affects almost one in ten individuals. It is known that people with diabetes are found more often among hospitalized or intensive care units (ICU) patients than among the general population.

In fact hardly any data are available on the prevalence of diabetes in hospitals. Therefore, scientists have assessed the diabetes prevalence, proportion of undiagnosed cases, the effectiveness of diabetes screening in a university hospital, the consequences for hospital stay and acquired complications.

Scientists at the University Hospital Tȕbingen (Tübingen Germany) screened 3,733 adult patients in Tübingen University Hospital for diabetes and prediabetes over a period of four weeks where blood samples were available. Diabetes diagnosis was defined as HbA1c equal to or greater than 6.5% and/or previously documented diabetes diagnosis; prediabetes was defined as HbA1c equal to or less than 5.7% and less than 6.5% without history of previous diabetes.

The result of the screening was that almost every fourth hospital patient suffered from diabetes (22%) that had a long-term blood glucose level (HbA1c value) of 6.5 % or higher. 24% of the patients in the study had a long-term blood glucose value between 5.7% and 6.4%. These values indicate an early stage of diabetes (prediabetes). Nearly 4% of the investigated patients had undiagnosed diabetes. The study also showed that patients with diabetes required treatment in the hospital approximately 1.47 days longer than patients with the same diagnosis without diabetes or prediabetes. The affected patients also had a higher risk of complications: 24% of the patients with diabetes experienced complications. In comparison, only 15% of the patients without diabetes were affected by complications.

The authors concluded that every fourth patient in the university hospital had diabetes and every second had either prediabetes or diabetes. It is also worthwhile to screen for unknown diabetes in patients over the age of 50. The high prevalence and negative consequences of diabetes require-screening and intensified specialized diabetes treatment in hospitals. The prevalence of hospital-acquired complications was higher in diabetic patients 197 of 630 compared with no diabetes: 447 of 2,459. The study was published on July 27, 2017, in the journal Experimental and Clinical Endocrinology & Diabetes.

Related Links:
University Hospital Tȕbingen

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more